NCT06244420Completed
Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis
Source: ClinicalTrials.gov · Last updated 1 Apr 2025
Brief summary (registry, in English)
The purpose of the study is to assess whether there is a correlation between imaging and histology with prognosis in patients with soft tissue and bone MC from the archives of the Rizzoli Orthopaedic Institute all the patients with a histological diagnosis of soft tissue or bone malignant myoepithelioma treated from 1998 to 2021
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 33 (actual)
- First submitted
- 29 Jan 2024
- Start date
- 10 Jan 2024
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Istituto Ortopedico Rizzoli
- NCT number
- NCT06244420
What you commit to
- Study type: Observational
- Participants enrolled: 33
- From 10 Jan 2024 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- At least one inclusion criterion not met
Who the study is looking for
- Male and female patients treated at Rizzoli Orthopaedic Institute between 01 Jan 1998 and 31 Dec 2021
- Age ≥ 2 years old
- Diagnosis of soft tissue or bone malignant myoepithelioma (MC-SB)
- Patients with available clinical and imaging data
Age in the registry: 2 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Itituto Ortopedico Rizzoli Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.